Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
+50% in 13 Tagen - Steht der große Ausbruch jetzt bevor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
11.06.Harbour BioMed Adds Luisa Salter-Cid as Scientific Advisor
11.06.PharmaEssentia Acquires Forus Therapeutics, Expanding Footprint in Canada
11.06.Chiesi Group Acquires KalVista Pharmaceuticals for $1.9B
11.06.ACG Packaging Materials Achieves ISO Certification for Croatia Facility
11.06.Cytovance Biologics Adds Cell Line Development Services
10.06.Verge Labs, Tenacia Biotech Unite to Advance CNS Pipeline
10.06.Axplora to Consolidate UDCA Manufacturing at Vizag, India Site by End of 2026
10.06.Genesis and Alnylam Expand Partnership to Commercialize RNAi Therapeutics for Nordic Region
10.06.AmMax Bio, Lonza Enter Non-Exclusive Licensing Agreement for AMB-104
10.06.Symeres Expands Spray Drying Capabilities in Cranbury, NJ
10.06.FibroFind Names New CEO, Adds Three Senior Hires
10.06.Lonza Appoints Hans Trees as Global Head of Communications
10.06.Sanofi Halts MOBILIZE Phase 3 Study of Riliprubart
10.06.FDA Approves EBGLYSS 8-Week Dosing
10.06.Orionis Biosciences, Novartis Partner to Advance Molecular Glue Drugs
09.06.CatalYm Announces New Chief Financial Officer Peter Garcia
09.06.Syntax Bio Pairs With Mayo Clinic on Stem-Cell Pancreatic Cell Therapies for Type 1 Diabetes
09.06.Syntis Bio Taps Matthew Dallas as CFO
09.06.GSK Agrees to Acquire Nuvalent for $10.6B
08.06.AdvanCell Names New CTO and CSO, Expanding Executive Leadership Team
08.06.Shilpa Medicare, Gate2Brain Partner to Advance First-in-Class Brain Cancer Therapy
08.06.J&J Agrees to Acquire Firefly Bio for $1B
08.06.Pfizer's Hympavzi Gets FDA Approval for Expanded Indication
08.06.Roche Strikes $2.3B Nurix Deal for BTK Degrader
08.06.Stevanato Group Introduces New Proprietary Pen Injector Platform